Alembic Pharmaceuticals’ arm to acquire Utility Therapeutics

03 Jul 2025 Evaluate

Alembic Pharmaceuticals’ wholly owned subsidiary -- Alembic Pharmaceuticals Inc is all set to acquire Utility Therapeutics (Utility). The objective behind the acquisition is to market the USFDA approved product and underdevelopment product owned by the Utility in USA. The transaction is expected to complete within 30 days. The cost of acquisition is around $12 million in staggered manner over period of time, depending on milestones achieved.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

712.25 0.00 (0.00%)
10-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1838.05
Dr. Reddys Lab 1317.20
Cipla 1331.00
Zydus Lifesciences 928.25
Lupin 2349.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×